Neurodegenerative Care Alzheimer’s

Stem Cell Therapy for
Alzheimer’s Disease

Alzheimer’s affects 55 million people worldwide — a number growing every 3 seconds. Emerging research shows that stem cell therapy for Alzheimer’s disease can slow neurodegeneration, reduce inflammation, and support cognitive recovery where conventional medicine falls short.

Advanced Neurological Protocol

Targeted Cellular Regeneration

  • Aims to mitigate progressive neurodegeneration and brain tissue inflammation.

  • Formulated to support systemic neural pathway repair and cellular signaling.

  • Customized clinical management protocols tailored to cognitive stages.

Global Clinical Scope

Treatment Of More Than 25 Diseases With Stem Cells.

Clinical Profile

Understanding
Alzheimer’s Disease

Alzheimer’s disease is the most common and progressive form of dementia, accounting for 60–80% of all dementia diagnoses. Every 3 seconds, someone worldwide is diagnosed. It progressively impairs memory, thinking, behavior, and eventually the ability to carry out daily tasks.

The disease primarily targets the brain’s neurons—particularly those responsible for memory and cognition—causing them to malfunction and die. As the condition advances, widespread brain atrophy occurs, leading to severe cognitive and functional decline.

Currently, no conventional pharmaceutical has succeeded in reversing Alzheimer’s progression. This is why stem cell therapy for Alzheimer’s disease has emerged as one of the most actively researched frontiers in neuroscience.


Pathology

Primary Drivers of Neurodegeneration

While the definitive cause remains complex, research focuses on four destructive mechanisms within cerebral tissue that stem cell protocols target to support repair.

01

Genetic Factors

Mutations in genes like APP, PSEN1, and PSEN2 increase amyloid production. The APOE-e4 allele is the most significant genetic risk factor for late-onset progression.

02

Neuroinflammation

Chronic brain inflammation activates microglia and astrocytes, triggering a destructive cascade of cytokines that accelerate tau protein misfolding.

03

Amyloid Plaques

Toxic amyloid beta plaques accumulate between neurons, completely disrupting synaptic signaling arrays and triggering cellular apoptosis.

04

Mass Synaptic Loss

Progressive destruction of synaptic connections—the communication bridges between neurons—leads directly to memory loss and behavioral decline.

Symptomatic Matrix

Evolution of Symptoms Across Cognitive Stages

Alzheimer’s symptoms evolve through early, middle, and late stages. While initial signs may be subtle, they progress with increasing severity over time.

Critical Window

Early Intervention Matters

According to clinical data, stem cell treatments show the highest efficacy when initiated during early-to-mid stages of the disease, before widespread, irreversible neuronal death occurs.

• Confusion
• Sleep Cycle Disruption
• Clinical Depression
• Chronic Restlessness
• Rapid Mood Swings
• Accelerating Forgetfulness
• Behavioral Aggressiveness
• Progressive Social Avoidance
• Trust Erosion / Paranoia
• Apathy & Severe Energy Loss
Advanced Science

Alzheimer’s Treatment

Alzheimer’s disease is the most common cause of dementia, and traditional treatments provide limited long-term results. Recent studies, including stem cell therapy Alzheimer’s clinical trials, suggest that regenerative medicine may offer new possibilities.

Mesenchymal Stem Cells (MSCs) Mechanism

Stem cell therapy for Alzheimer’s disease uses mesenchymal stem cells (MSCs) to support neuronal repair, reduce inflammation, and improve cognitive function.

Neuronal Repair
Anti-Inflammation
Cognitive Support
Advanced Therapeutics

Treatment of Alzheimer’s
with Stem Cells

Acetylcholine is a critical neurotransmitter at synapses, enabling neurons to communicate. In Alzheimer’s disease, this system deteriorates rapidly. Our stem cell therapy for Alzheimer’s introduces hUC-MSCs (Human Umbilical Cord Mesenchymal Stem Cells) that actively support and rebuild this pathway.

These specialized cells release the essential neurotrophic factor BDNF (Brain-Derived Neurotrophic Factor), which increases synapse density between neurons. Concurrently, they secrete ChAT (Choline Acetyltransferase), directly improving acetylcholine synthesis across the brain to preserve critical neural networks.

Due to their specialized homing mechanisms, these cells migrate directly to areas of injury in the brain, crossing the blood-brain barrier to reduce oxidative stress and prevent further cell death. Clinical data demonstrates that hUC-MSCs can develop into neuroblast precursor cells—early-stage neurons—providing a functional biological foundation for neural regeneration.

Secreted Growth Factors Supporting Cortical Regrowth

Intravenously injected stem cells safely cross the blood-brain barrier to deliver these critical factors directly to the affected cortex and grey matter without requiring immune suppression.

IGF-1 (Insulin-like Growth Factor 1)
GGF-1 (Glucagon-like Growth Factor 1)
BDNF (Brain-Derived Neurotrophic Factor)
VEGF (Vascular Endothelial Growth Factor)
GDNF (Glial Cell-Derived Neurotrophic Factor)
Mode of Action

6 Ways Stem Cells Act Against Alzheimer’s

01

Anti-Inflammatory

Reduces pro-inflammatory neural cytokines and microglial over-activation that accelerates neuronal death.

02

Neuroprotective

Creates a regenerative microenvironment that reduces oxidative stress and actively supports surviving neurons.

03

Neural Regeneration

Stimulates neurogenesis, angiogenesis, and cell differentiation—helping rebuild damaged brain circuits.

04

Plaque Inhibition

Shown to suppress beta-amyloid plaque formation and help clear existing plaques from neural tissue.

05

Synaptic Support

Increases release of BDNF and ChAT to strengthen synaptic communication and improve signal transmission.

06

Vascular Health

Promotes angiogenesis, improving blood flow to oxygen-deprived brain regions critical for sustained cognition.

ClinicalTrials.gov Data

ClinicalTrials.gov Evidence: Animal studies and early-phase stem cell therapy Alzheimer’s clinical trials have demonstrated verified improvements in memory function, task performance, and new nerve cell formation in treated subjects.

Precision Protocol

Treatment Protocol to Treat Alzheimer’s with Stem Cells

At Stem Cells Bio Clinic, we recommend hUC-MSCs for Alzheimer’s treatment. This 5-day precision protocol is administered under continuous clinical monitoring by our expert neurological team.

Day 1: Infusion of hUC-MSCs + Exosomes

Initial intravenous infusion of umbilical cord mesenchymal stem cells combined with regenerative exosomes to establish a neuroprotective environment.

Day 2: Antioxidant Therapy with Vitamin C

High-dose intravenous Vitamin C therapy to reduce oxidative stress, protect newly introduced stem cells, and enhance cellular uptake efficiency.

Book Your Appointment Today

Benefits of hUC-MSC Therapy

Minimal recovery time — patients are ambulatory and can resume activities promptly.
Home-like setting — reducing patient stress and supporting a calm environment.
Higher purity — umbilical cord-derived MSCs show higher proliferation rates.
Clinical Overview

Challenges in Treating Alzheimer’s Disease

Alzheimer’s disease involves diverse cellular dysfunction across large areas of the brain, making it uniquely complex to treat.

Stem cell therapy represents the most promising approach to slow disease progression, preserve function, and improve quality of life. Our therapy is personalized, with protocols adapted to each patient’s specific biomarkers.

How are Stem Cells Collected?

We focus on delicate, specialized techniques to collect from the donor’s umbilical cord and placenta with parental consent, following strict WHO ethical guidelines.

How are Stem Cells managed?

We primarily utilize an intravenous route, though intra-pulmonary routes are also available based on the donor’s condition.

All about Stem Cells Bio Clinic

Located in Costa Rica, our clinic features a professional team of doctors, nurses, and theatre staff specializing in stem cell treatments for osteoarthritis and other conditions. We provide cost-effective, intensive care.

Book Your Appointment Today

Scientific References:

01

Liu XY, Yang LP, Zhao L. Stem cell therapy for Alzheimer’s. World J Stem Cells. 2020 Aug 26;12(8):787-802. doi: 10.4252/wjsc.v12.i8.787

02

Alzheimer’s Association. 2017 Alzheimer’s Disease Facts and Figures. Alzheimer’s Dement 2017;13:325-373.

03

Kang, Jae Myeong, et al. Stem Cell Therapy for Alzheimer’s Disease: A Review of Recent Clinical Trials. Jan 1 2016: 879 – 889.

04

Tang Jun, How close is the stem cell cure to Alzheimer’s disease: Future and Beyond? Neural Regen Res. 2012 Jan 5; 7(1): 66–71.

05

A. E. Hernández, E. García, “Mesenchymal Stem Cell Therapy for Alzheimer’s Disease,” Stem Cells International, vol. 2021, Article ID 7834421. https://doi.org/10.1155/2021/7834421

06

Thomas Duncan and Michael Valenzuela. Alzheimer’s disease, dementia, and stem cell therapy. Stem Cell Research & Therapy (2017) 8:111.

07

Han, F., Bi, J., Qiao, L., Arancio, O. (2020). Stem Cell Therapy for Alzheimer’s Disease. In: Han, F., Lu, P.(. (eds) Stem Cell-based Therapy for Neurodegenerative Diseases. Advances in Experimental Medicine and Biology, vol 1266. https://doi.org/10.1007/978-981-15-4370-8_4

08

Salloway S, et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease. N Engl J Med. 2014;370:322–33.